Page 216 - Tata_Chemicals_yearly-reports-2020-2021

Integrated Annual Report 2020-21

45.2 Contingent assets ` in crore

As at As at
March 31, 2021 March 31, 2020
(i) Income Tax
(pending before Appellate authorities in respect of which the Company is in appeal) 78.94 78.40

46. Approval of Standalone Financial Statements
The Standalone Financial Statements were approved for issue by the Board of Directors on May 3, 2021.

Signatures to notes forming part of the Standalone Financial Statements 1 - 46

As per our report of even date attached For and on behalf of the Board
For B S R & Co. LLP N. Chandrasekaran Chairman
Chartered Accountants (DIN: 00121863) Director
Padmini Khare Kaicker
Firm's Registration No: 101248W/W - 100022 (DIN: 00296388)
R. Mukundan Managing Director and CEO
Vijay Mathur (DIN: 00778253)
Partner Nandakumar S. Tirumalai Chief Financial Officer
(ICAI M. No.: 203896)
Membership No. 046476 Rajiv Chandan General Counsel & Company Secretary
Mumbai, May 3, 2021 (ICSI M. No.: FCS 4312)

214